• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于双期增强CT的影像组学列线图预测IV期肺腺癌无进展生存期

Dual-Phase Enhanced CT-Derived Radiomics Nomogram for Progression-Free Survival Prediction in Stage IV Lung Adenocarcinoma.

作者信息

Sun Haitao, Peng Zhaohui, Chen Guoyue, Dai Zhengjun, Yao Jian, Zhou Peng

机构信息

Medical Imaging Center of Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.

Scientific Research Department of Huiying Medical Technology Co. Ltd, Beijing, China.

出版信息

Cancer Med. 2024 Dec;13(23):e70473. doi: 10.1002/cam4.70473.

DOI:10.1002/cam4.70473
PMID:39651734
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11626483/
Abstract

PURPOSE

The objective is to establish a radiomics nomogram (Rad-nomogram) using dual-phase enhanced computed tomography (DPE-CT) for the prediction of progression-free survival (PFS) in patients diagnosed with stage IV lung adenocarcinoma (ADC).

METHODS

From DPE-CT scans, radiomic characteristics were retrieved from 133 patients diagnosed with stage IV lung ADC. Clinical data were analyzed using univariate and multivariate Cox regression analyses. The radiomics signature was combined with clinical features employing multivariate Cox analysis in order to develop a Rad-nomogram. The predictive efficiency of the nomogram was evaluated using survival studies, such as Kaplan-Meier curves and Harrell's C-index. The benefits and clinical utility of various models were compared using the net reclassification index (NRI), decision curve analysis (DCA), and integrated discrimination improvement (IDI).

RESULTS

In the test cohort, the C-indexes for the clinical, artery, and vein phase CT models were 0.675, 0.691, and 0.678, respectively. The dual-phase achieved a C-index of 0.731, exceeding the CT model, while the developed nomogram reached a C-index of 0.783. The Kaplan-Meier survival study classified patients into low-risk and high-risk groups related to PFS using the Rad-nomogram (p < 0.05). The Rad-nomogram demonstrated a greater net advantage when compared with clinical and Rad models, as indicated by positive values of the NRI and IDI (ranging from 11.6% to 52.6%, p < 0.05).

CONCLUSION

The Rad-nomogram, employing DPE-CT scans, offers a promising approach to predict PFS in individuals diagnosed with stage IV lung ADC.

摘要

目的

本研究旨在利用双期增强计算机断层扫描(DPE-CT)建立一种影像组学列线图(Rad-列线图),用于预测IV期肺腺癌(ADC)患者的无进展生存期(PFS)。

方法

从133例IV期肺ADC患者的DPE-CT扫描中提取影像组学特征。采用单因素和多因素Cox回归分析临床数据。通过多因素Cox分析将影像组学特征与临床特征相结合,以建立Rad-列线图。采用生存研究(如Kaplan-Meier曲线和Harrell C指数)评估列线图的预测效率。使用净重新分类指数(NRI)、决策曲线分析(DCA)和综合判别改善(IDI)比较各种模型的优势和临床实用性。

结果

在测试队列中,临床、动脉期和静脉期CT模型的C指数分别为0.675、0.691和0.678。双期模型的C指数为0.731,超过了CT模型,而所建立的列线图的C指数达到了0.783。Kaplan-Meier生存研究使用Rad-列线图将患者分为与PFS相关的低风险和高风险组(p<0.05)。NRI和IDI的正值表明,与临床和Rad模型相比,Rad-列线图具有更大的净优势(范围为11.6%至52.6%,p<0.05)。

结论

采用DPE-CT扫描的Rad-列线图为预测IV期肺ADC患者的PFS提供了一种有前景的方法。

相似文献

1
Dual-Phase Enhanced CT-Derived Radiomics Nomogram for Progression-Free Survival Prediction in Stage IV Lung Adenocarcinoma.基于双期增强CT的影像组学列线图预测IV期肺腺癌无进展生存期
Cancer Med. 2024 Dec;13(23):e70473. doi: 10.1002/cam4.70473.
2
Development and validation of a CT-based radiomics nomogram for predicting progression-free survival in patients with small cell lung cancer.基于CT的影像组学列线图在预测小细胞肺癌患者无进展生存期方面的开发与验证
BMC Med Imaging. 2025 May 6;25(1):154. doi: 10.1186/s12880-025-01691-4.
3
Radiomics Nomogram Based on Optimal Volume of Interest Derived from High-Resolution CT for Preoperative Prediction of IASLC Grading in Clinical IA Lung Adenocarcinomas: A Multi-Center, Large-Population Study.基于高分辨率 CT 最优感兴趣区体积的放射组学列线图预测临床 IA 期肺腺癌 IASLC 分级:多中心大样本研究。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241300734. doi: 10.1177/15330338241300734.
4
Radiomics for lung adenocarcinoma manifesting as pure ground-glass nodules: invasive prediction.肺腺癌纯磨玻璃结节的影像组学分析:侵袭性预测。
Eur Radiol. 2020 Jul;30(7):3650-3659. doi: 10.1007/s00330-020-06776-y. Epub 2020 Mar 11.
5
Preoperative CT and Radiomics Nomograms for Distinguishing Bronchiolar Adenoma and Early-Stage Lung Adenocarcinoma.用于鉴别细支气管腺瘤和早期肺腺癌的术前CT及影像组学列线图
Acad Radiol. 2025 Feb;32(2):1054-1066. doi: 10.1016/j.acra.2024.08.047. Epub 2024 Sep 10.
6
A CT-based radiomics nomogram for predicting the progression-free survival in small cell lung cancer: a multicenter cohort study.基于CT的影像组学列线图预测小细胞肺癌无进展生存期:一项多中心队列研究
Radiol Med. 2023 Nov;128(11):1386-1397. doi: 10.1007/s11547-023-01702-w. Epub 2023 Aug 19.
7
Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma.代谢参数对基于 PET/CT 影像组学列线图预测肺腺癌血管淋巴管侵犯及预后的附加价值。
Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):217-230. doi: 10.1007/s00259-020-04747-5. Epub 2020 May 25.
8
A combination of radiomic features, clinic characteristics, and serum tumor biomarkers to predict the possibility of the micropapillary/solid component of lung adenocarcinoma.联合放射组学特征、临床特征和血清肿瘤标志物预测肺腺癌微乳头/实性成分的可能性。
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241249168. doi: 10.1177/17534666241249168.
9
Longitudinal CT Radiomics to Predict Progression-free Survival in Patients with Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy.纵向CT影像组学预测局部晚期胃癌新辅助化疗后无进展生存期
Acad Radiol. 2025 May;32(5):2618-2629. doi: 10.1016/j.acra.2024.11.068. Epub 2024 Dec 27.
10
A nomogram-based survival prediction model for non-small cell lung cancer patients based on clinical risk factors and multiregion radiomics features.基于临床风险因素和多区域放射组学特征的非小细胞肺癌患者列线图生存预测模型。
Clin Radiol. 2025 May;84:106826. doi: 10.1016/j.crad.2025.106826. Epub 2025 Feb 13.

本文引用的文献

1
Multi-classification model incorporating radiomics and clinic-radiological features for predicting invasiveness and differentiation of pulmonary adenocarcinoma nodules.纳入放射组学和临床-放射学特征的多分类模型预测肺腺癌结节的侵袭性和分化程度。
Biomed Eng Online. 2023 Nov 30;22(1):112. doi: 10.1186/s12938-023-01180-1.
2
Nomograms integrating CT radiomic and deep learning signatures to predict overall survival and progression-free survival in NSCLC patients treated with chemotherapy.联合 CT 放射组学和深度学习特征的列线图预测接受化疗的 NSCLC 患者的总生存期和无进展生存期。
Cancer Imaging. 2023 Oct 22;23(1):101. doi: 10.1186/s40644-023-00620-4.
3
Application of radiomics based on chest CT-enhanced dual-phase imaging in the immunotherapy of non-small cell lung cancer.
基于胸部 CT 增强双期扫描的影像组学在非小细胞肺癌免疫治疗中的应用。
J Xray Sci Technol. 2023;31(6):1333-1340. doi: 10.3233/XST-230189.
4
A CT-based radiomics nomogram for predicting the progression-free survival in small cell lung cancer: a multicenter cohort study.基于CT的影像组学列线图预测小细胞肺癌无进展生存期:一项多中心队列研究
Radiol Med. 2023 Nov;128(11):1386-1397. doi: 10.1007/s11547-023-01702-w. Epub 2023 Aug 19.
5
Radiomics nomogram for the prediction of Ki-67 index in advanced non-small cell lung cancer based on dual-phase enhanced computed tomography.基于双期增强 CT 的放射组学列线图预测晚期非小细胞肺癌 Ki-67 指数
J Cancer Res Clin Oncol. 2023 Sep;149(11):9301-9315. doi: 10.1007/s00432-023-04856-2. Epub 2023 May 19.
6
Prediction of platinum resistance for advanced high-grade serous ovarian carcinoma using MRI-based radiomics nomogram.基于MRI的影像组学列线图预测晚期高级别浆液性卵巢癌的铂耐药性
Eur Radiol. 2023 Aug;33(8):5298-5308. doi: 10.1007/s00330-023-09552-w. Epub 2023 Mar 30.
7
Development and validation of a radiomics-based nomogram for predicting a major pathological response to neoadjuvant immunochemotherapy for patients with potentially resectable non-small cell lung cancer.基于放射组学的Nomogram 模型预测潜在可切除的非小细胞肺癌患者新辅助免疫化疗主要病理缓解的开发和验证。
Front Immunol. 2023 Feb 16;14:1115291. doi: 10.3389/fimmu.2023.1115291. eCollection 2023.
8
Prediction of VEGF and EGFR Expression in Peripheral Lung Cancer Based on the Radiomics Model of Spectral CT Enhanced Images.基于光谱CT增强图像的放射组学模型预测周围型肺癌中VEGF和EGFR的表达
Int J Gen Med. 2022 Aug 22;15:6725-6738. doi: 10.2147/IJGM.S374002. eCollection 2022.
9
Radiomics based on enhanced CT for differentiating between pulmonary tuberculosis and pulmonary adenocarcinoma presenting as solid nodules or masses.基于增强 CT 的影像组学在鉴别表现为实性结节或肿块的肺结核和肺腺癌中的应用。
J Cancer Res Clin Oncol. 2023 Jul;149(7):3395-3408. doi: 10.1007/s00432-022-04256-y. Epub 2022 Aug 8.
10
Radiomics combined with clinical characteristics predicted the progression-free survival time in first-line targeted therapy for advanced non-small cell lung cancer with EGFR mutation.基于影像组学特征与临床特征的模型预测表皮生长因子受体突变的晚期非小细胞肺癌患者一线靶向治疗的无进展生存期。
BMC Res Notes. 2022 Apr 14;15(1):140. doi: 10.1186/s13104-022-06019-x.